Your browser doesn't support javascript.
loading
A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma.
Palomba, M Lia; Ghione, Paola; Patel, Anik R; Nahas, Myrna; Beygi, Sara; Hatswell, Anthony J; Kanters, Steve; Limbrick-Oldfield, Eve H; Wade, Sally W; Ray, Markqayne D; Owen, Jessica; Neelapu, Sattva S; Gribben, John; Radford, John; Bobillo, Sabela.
Affiliation
  • Palomba ML; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ghione P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Patel AR; Kite, A Gilead Company, Santa Monica, CA, USA.
  • Nahas M; Kite, A Gilead Company, Santa Monica, CA, USA.
  • Beygi S; Kite, A Gilead Company, Santa Monica, CA, USA.
  • Hatswell AJ; Delta Hat, Nottingham, UK.
  • Kanters S; RainCity Analytics, Vancouver, BC, Canada.
  • Limbrick-Oldfield EH; RainCity Analytics, Vancouver, BC, Canada.
  • Wade SW; Wade Outcomes Research and Consulting, Salt Lake City, UT, USA.
  • Ray MD; Kite, A Gilead Company, Santa Monica, CA, USA.
  • Owen J; Delta Hat, Nottingham, UK.
  • Neelapu SS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gribben J; Cancer Research UK Barts Centre, London, UK.
  • Radford J; The University of Manchester and Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Bobillo S; Vall D'Hebron Institute of Oncology, Barcelona, Spain.
Expert Rev Anticancer Ther ; 23(2): 199-206, 2023 02.
Article in En | MEDLINE | ID: mdl-36723678

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Products / Lymphoma, Follicular / Lymphoma, Large B-Cell, Diffuse Type of study: Prognostic_studies Limits: Humans Language: En Journal: Expert Rev Anticancer Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biological Products / Lymphoma, Follicular / Lymphoma, Large B-Cell, Diffuse Type of study: Prognostic_studies Limits: Humans Language: En Journal: Expert Rev Anticancer Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication: